An evidence based systematic review of remifentanil associated opioid-induced hyperalgesia

Author： Rivosecchi Ryan M   Rice Mark J   Smithburger Pamela L   Buckley Mitchell S   Coons James C   Kane-Gill Sandra L  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.13, Iss.5, 2014-05, pp. : 587-603

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Methylnaltrexone for opioid-induced constipation

By  

Inpharma, Vol. 1, Iss. 1641, 2008-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Opioid-induced Cardioprotection

By  

Current Pharmaceutical Design, Vol. 20, Iss. 36, 2014-11 ,pp. : 5696-5705

Bentham Science Publishers

Access to resources Recommend Favorite

Methylnaltrexone for opioid-induced constipation

By  

Reactions Weekly, Vol. 1, Iss. 1205, 2008-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Opioid-Induced Pruritus

By Benson Jessica L.   Campbell Hope E.   Phillips Cory N.  

The Consultant Pharmacist, Vol. 30, Iss. 4, 2015-04 ,pp. : 221-227

American Society of Consultant Pharmacists

Access to resources Recommend Favorite

Cost analyses of remifentanil, mivacurium and ropivacaine – a systematic review

By Vassiliou Timon   Putzke Caroline   Geldner Götz   Eberhart Leopold  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 2, 2004-02 ,pp. : 415-425

Informa Healthcare

Access to resources Recommend Favorite